SXR1096 / Sixera - LARVOL DELTA

A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome (clinicaltrials.gov) - P1/2 | N=9 | Completed | Sponsor: Sixera Pharma | Recruiting ➔ Completed | N=20 ➔ 9 | Trial completion date: Dec 2022 ➔ Aug 2025 | Trial primary completion date: Aug 2022 ➔ Jun 2025

Enrollment change • First-in-human • Trial completion • Trial completion date • Trial primary completion date